Archford Capital Strategies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Archford Capital Strategies’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-35	Closed	-$6K	–	551
2019 Q2	$6K	Hold	35	–	–	﹤0.01%	445
2019 Q1	$6K	Buy	+35	New	+$5.21K	﹤0.01%	423
2016 Q1	–	Sell	-304	Closed	-$22K	–	660
2015 Q4	$22K	Buy	304 +96	+46%	+$7.82K	0.01%	367
2015 Q3	$19K	Hold	208	–	–	0.01%	280
2015 Q2	$26K	Buy	+208	New	+$23.6K	0.02%	249

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Archford Capital Strategies's GWPH Position: Q3 2019 in Review

Archford Capital Strategies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 35 shares — an estimated $6K sold.

Archford Capital Strategies first reported a position in GWPH in Q2 2015 and held it in 5 quarters. The position peaked at $26K in Q2 2015. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Archford Capital Strategies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Archford Capital Strategies sold 35 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $6K.
Archford Capital Strategies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and held it in 5 quarters.
Archford Capital Strategies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $26K in Q2 2015.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.